Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
Terminated
161 enrolled
Plasma Biomarkers C-RAC, ICORG 12-27, V1
Terminated
109 enrolled
Lithium
Phase 1 Terminated
2 enrolled
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Phase 3 Terminated
406 enrolled 14 charts
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Phase 3 Terminated
19 enrolled
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
Phase 3 Terminated
859 enrolled 8 charts
TRI-LARC
Phase 1/2 Terminated
94 enrolled
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
Phase 3 Terminated
G-LUCAS
Phase 2 Terminated
8 enrolled
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Phase 2 Terminated
20 enrolled 9 charts
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
29 enrolled
Colorectal Cancer (CRC) Cetuximab Elderly Frail
Phase 2 Terminated
5 enrolled
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Phase 2 Terminated
22 enrolled 9 charts
Net-Pac
Phase 3 Terminated
5 enrolled
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
Phase 1 Terminated
14 enrolled
Irinotecan in Treating Patients With Colorectal Cancer
Terminated
28 enrolled
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Phase 3 Terminated
22 enrolled 3 charts
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Phase 3 Terminated
9 enrolled 6 charts
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
Phase 3 Terminated
18 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
Phase 3 Terminated
144 enrolled
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
Phase 2 Terminated
119 enrolled
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Phase 2/3 Terminated
88 enrolled
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
Phase 3 Terminated
12 enrolled
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
Phase 2 Terminated
7 enrolled 7 charts
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
Phase 2 Terminated
Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
Phase 3 Terminated
700 enrolled